Skip to main content
Log in

Subcutaneous botulinum toxin type A inhibits regional sweating: an individual observation

  • Case Report
  • Published:
Clinical Autonomic Research Aims and scope Submit manuscript

Abstract

Botulinum toxin inhibits neuromuscular transmission by blocking the exocytosis of acetylcholine. It was tested for a similar effect on cholinergic postganglionic sympathetic neurones at the sudomotor junction. Subcutaneous injections of 0.1 and 1.0 units of type A botulinum toxin into the forearm of a healthy subject abolished local thermoregulatory sweating in cutaneous regions spanning 1.0 and 1.5 cm for nearly 1 year without producing weakness. Botulinum toxin, therefore appears to have potent anhidrotic activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sugiyama H.Clostridium botulinum neurotoxin.Microbiol Rev 1980;44: 419–448.

    Google Scholar 

  2. Simpson LL. Molecular pharmacology of botulinum toxin and tetanus toxin.Annu Rev Pharmacol Toxicol 1986;26: 427–453.

    Google Scholar 

  3. Oguma K, Fujinaga Y, Onone K. Structure and function ofClostridium botulinum toxins.Microbiol Immunol 1995;39: 161–168.

    Google Scholar 

  4. Valtorta F, Arslan G. The pharmacology of botulinum toxin.Pharmacol Res 1993;27: 33–44.

    Google Scholar 

  5. Hughes JM, Botulism. In: Scheld WM, Whitley RJ, Durack DT, eds.Infections of the Central Nervous System. New York: Raven Press, 1991; 589–602.

    Google Scholar 

  6. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin.New Engl J Med 1991;324: 1186–1194.

    Google Scholar 

  7. Jenzer G, Mumenthaler M, Ludin HP, Robert F. Autonomic dysfunction in botulism B: a clinical report.Neurology 1975;25: 150–153.

    Google Scholar 

  8. Fealey RD. The thermoregulatory sweat test. In: Low, PA, ed.Clinical Autonomic Disorders. Boston: Little, Brown & Co, 1993: 217–229.

    Google Scholar 

  9. Gonnering RS. Pharmacology of botulinum toxin.Int Ophthalmol Clin 1993;33: 203–226.

    Google Scholar 

  10. Gutmann L, Oguchi K, Chou SM. Neuromuscular junction in human botulism.Neurology 1973;23: 424–425.

    Google Scholar 

  11. Sellin LC. The action of botulinum toxin at the neuromuscular junction.Med Biol 1981;59: 11–20.

    Google Scholar 

  12. Duchen LW. Motor nerve growth induced by botulinum toxin as a regenerative phenomenon.Proc R Soc Med 1972;65: 196–197.

    Google Scholar 

  13. Pamplett R. Early terminal and nodal sprouting of motor axons after botulinum toxin.J Neurol Sci 1989;92: 181–192.

    Google Scholar 

  14. Masters A, Rennie JA. Endoscopic transthoracic sympathectomy for idiopathic upper limb hyperhidrosis.Clin Autonom Res 1992;2: 349–352.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cheshire, W.P. Subcutaneous botulinum toxin type A inhibits regional sweating: an individual observation. Clinical Autonomic Research 6, 123–124 (1996). https://doi.org/10.1007/BF02291235

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02291235

Keywords

Navigation